Coya Therapeutics (COYA) Price to Book (2022 - 2026)

Coya Therapeutics has disclosed Price to Book across 5 years of filings, most recently posting 3.17 for Q2 2026.

• In Q2 2026, Price to Book fell 6.65% year-over-year to 3.17; the TTM figure through Jun 2026 stood at 3.17 (down 6.65% YoY), while the FY2025 annual figure was 2.26, down 6.77% from the prior year.
• Price to Book came in at 3.17 for Q2 2026 at Coya Therapeutics, up from 1.89 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 4.48 in Q1 2024 to a low of 1.46 in Q4 2022.
• Average Price to Book over 5 years is 2.66, with a median of 3.06 recorded in 2023.
• Year-over-year, Price to Book soared 244.49% in 2023 and sank 41.8% in 2026.
• Over 5 years, Price to Book stood at 1.46 in 2022, then surged by 244.49% to 2.11 in 2023, then climbed by 14.45% to 2.42 in 2024, then fell by 6.77% to 2.26 in 2025, then soared by 40.61% to 3.17 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 3.17 in Q2 2026, 1.89 in Q1 2026, and 2.26 in Q4 2025.